Reproductive Genetics

Reproductive Genetics Market Research Report: Forecast (2021-2026)

By Procedure Type (Carrier Screening, Pre-Natal Screening, Pre-Implantation Genetic Testing, Infertility Genetic Testing), By Product Type (Kits, Laboratory Developed Tests, Reagents & Consumables), B Read more

  • Healthcare
  • Jul 2021
  • 254
  • HC55017

Reproductive Genetics is the branch of science that deals with the relationship between reproduction and genotype. It involves various tests and procedures to offer needful information about the probabilities of having a child in case of any specific genetic disorder. Moreover, Reproductive Genetics further help predict & prevent genetic disorders during reproductive procedures.

The “Global Reproductive Genetics Market” is likely to grow at a CAGR of around 12% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The market growth primarily attributes to molecular diagnostics and rising awareness regarding genetic testing & screenings. With technological advancements, genetic tests are gaining excellent popularity in reproductive procedures. 

They assist in identifying the cause of infertility & carriers of inherited diseases, thereby helping in directing toward the most suitable assisted reproductive techniques. Hence, these factors are likely to fuel the Global Reproductive Genetics Market in the coming years

The research report, “Global Reproductive Genetics Market Analysis, 2021,” depicts a deep-dive market analysis of market statistics, including regional & country-wise market size, market forecast, CAGR & market share of different segments, competitive benchmarking, and key market drivers & restraints.

Report Coverage Details
Study Period Historical Data: 2016-19
Base Year: 2020
Forecast Period: 2021-26
CAGR (2021-2026) 12%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy
Asia-Pacific: China, India, Japan, South Korea, Australia
South America: Brazil, and Argentina
Key Companies Profiled ThermoFisher Scientific, Eurofins Scientific SE, Natera Inc., BGI Genomics, Illumina, Inc., Agilent Technologies, Inc., CENTOGENE AG, Fulgent Genetics, Inc., F. Hoffmann-La Roche Ltd, Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer, Inc., Myriad Genetics, Inc., OPKO Health, Inc., Quest Diagnostics, QIAGEN NV
Unit Denominations USD Million/Billion

 

COVID-19 Outbreak Negatively Impacted the Global Reproductive Genetics Market

The outbreak of the COVID-19 pandemic has resulted in the governments of different nations enforcing strict movement restrictions and the shutdown of clinics. During this time, consumers shifted their preferences toward tele consulting to avoid the risk of getting infected.

Additionally, the shortage of skilled human resources, infrastructure, and logistic issues also affected the overall healthcare system. The situation worsened further due to reduced access & decline in genetic testing globally owing to the extended lockdown in all regions.

However, reproductive genetic testing companies incorporated several measures, including supply chain centralization, to recover from the losses caused by the pandemic. Hence, the market shall regain its usual pace and attain significant growth in the forecast period.

Reproductive Genetics Market Research Report: Forecast (2021-2026)

Market Segmentation

Career Screening Dominated the Global Reproductive Genetics Market with Largest Share

Based on the Procedure Type, the market bifurcates into Carrier Screening, Pre-Natal Screening, Pre-Implantation Genetic Testing, and Infertility Genetic Testing. Among these segments, Carrier Screening accounted for more than 50% of the market share in the previous few years and is likely to maintain its dominance over the forecast period. 

Carrier Screening is a type of genetic test carried out on patients with a higher risk of passing on the genetic disorder to their children. The increased risk of genetic mutations and the wide-range utility of genetic testing at an early stage are the prime aspects that contributed to the adoption of Carrier Screening procedures.

Aneuploidy Captured the Significant Share of Global Reproductive Genetics Market

Based on the Application, the market divides into Aneuploidy, Structural Chromosomal Abnormality, and Single Gene Disorder. The Aneuploidy segment captured around 40% share of the Global Reproductive Genetics Market in the previous year. Most aneuploidies are considered lethal, claims experts. Additionally, their most common form is trisomy, present in 0.3% of all live births. Most cases of Aneuploidy result in miscarriage. Hence, the need for reproductive genetic consultation is significantly high in the cases of Aneuploidy, thereby propelling the overall market growth.

Regional Landscape

North America Attained the Highest Share of the Global Reproductive Genetics Market

Globally, North America acquired around 38% share of the Global Reproductive Genetics Market in the previous year. The U.S. remained the most dominating country in terms of revenue generation. Moreover, the presence of full-fledged operational units of conglomerate market players in the region is helping in the establishment of various start-up companies. Additionally, the several technological innovations of these players also propel the Global Reproductive Genetics Market.

Market Driver

Increasing Awareness and Acceptance for Genetic Testing and Screening

The growing literacy rate has led to a surge in the understanding levels regarding personal genomic risk, thereby impacting the public attitude and interest of the population globally. Furthermore, the rising public participation in personal genomics activities, including research and genomic services, has also fueled public awareness & understanding regarding genetics. Moreover, several educational programs run by the government and the emergence of direct-to-consumer (DTC) testing in the last few years have boosted the genomic healthcare knowledge among the population.

Market Challenge

Stringent Regulations & Norms to Restrain the Market Growth

Various regulatory bodies worldwide restrict the use of reproductive genetics tests as the subsequent rise in uptake of Pre-Natal testing is likely to surge the incidence of abortions. Therefore, professional organizations, such as the American College of Obstetricians and Gynecologists (ACOG), International Society for Pre-Natal Diagnosis, U.S. National Society of Genetic Counselors (NSGC), and the Japan Society of Obstetrics and Gynecology, have set up a few guidelines to limit the use of non-invasive Pre-Natal testing to pregnant women at high risk of chromosomal aneuploidies, thereby likely to hinder the overall market growth.

Competitive Landscape

According to MarkNtel Advisors, the leading industry players in the Global Reproductive Genetics market are ThermoFisher Scientific, Eurofins Scientific SE, Natera Inc., BGI Genomics, Illumina, Inc., Agilent Technologies, Inc., CENTOGENE AG, Fulgent Genetics, Inc., F. Hoffmann-La Roche Ltd., Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer, Inc., Myriad Genetics, Inc., OPKO Health, Inc., Quest Diagnostics, and QIAGEN NV.

Key Questions Answered in the Market Research Report:

  1. What are the overall market statistics or estimates (Market Overview, Market Size- by Value, Forecast Numbers, Market Segmentation, and Market Shares) of the Global Reproductive Genetics Market?
  2. What are the region-wise industry size, growth drivers, and challenges?
  3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Reproductive Genetics Market? 
  4. Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Global Reproductive Genetics Market based on a competitive benchmarking matrix?
  5. What are the key results derived from the market surveys conducted during the Global Reproductive Genetics Market study?

Market Outlook, Segmentation, and Statistics 

  • Impact of COVID-19 on Global Reproductive Genetics Market
  • Market Size & Analysis
    • By Revenue
  • Market Share & Analysis
    • By Procedure Type
      • Carrier Screening
      • Pre-Natal Screening
      • Pre-Implantation Genetic Testing
      • Infertility Genetic Testing
    • By Product Type
      • Kits
      • Laboratory Developed Tests
      • Reagents & Consumables
    • By Technology
      • Next Generation Sequencing
      • Polymerase Chain Reaction
      • In-Situ Hybridization
      • Microarray
    • By Application
      • Aneuploidy
      • Structural Chromosomal Abnormality        
      • Single Gene Disorder
      • Others   
    • By Region
      • North America
      • South America
      • Europe
      • Middle East & Africa
      • Asia Pacific
    • By Region
      • North America
      • South America
      • Europe
      • Middle East & Africa
      • Asia-Pacific
    • By Competitors
      • Competition Characteristics
      • Market Share & Analysis
      • Competitive Metrix
  • Global Reproductive Genetics Market Hotspots & Opportunities
  • Global Reproductive Genetics Market Regulations & Policy
  • Key Strategic Imperatives for Success and Growth
  • Global Competition Outlook
    • Competition Matrix
    • Company Profile

Frequently Asked Questions

A. The Global Reproductive Genetics Market is forecast to grow at a CAGR of 12% during 2021-26.

A. ThermoFisher Scientific, Eurofins Scientific SE, Natera Inc., BGI Genomics, Illumina, Inc., Agilent Technologies, Inc., CENTOGENE AG, Fulgent Genetics, Inc., F. Hoffmann-La Roche Ltd., Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer, Inc., Myriad Genetics, Inc., OPKO Health, Inc., Quest Diagnostics, and QIAGEN NV are a few of the leading players in the Global Reproductive Genetics Market.

A. The Carrier Screening segment is likely to attain the highest CAGR and maintain its significant market share during the forecast period, i.e., 2021-26.

A. North America continues to grow at the highest CAGR during 2021-26, thereby presenting immense opportunities to market players of the Global Reproductive Genetics Market.

A. The declining cost of genetic sequencing technologies, rising awareness & acceptance for genetic testing, burgeoning demand for early detection and prevention, and increasing maternal age leading to pregnancy complications are the major factors fueling the market growth.

A. The outbreak of the COVID-19 pandemic has negatively affected the Global Reproductive Genetics Market owing to the enforcement of movement restrictions, the shutdown of clinics, and logistic & infrastructure issues.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
    4. Market Segmentation
  2. Preface
  3. Executive Summary
  4. Impact of COVID-19 on Global Reproductive Genetics Market
  5. Global Reproductive Genetics Market Dynamics
    1. Drivers
    2. Challenges
  6. Global Reproductive Genetics Market Hotspot & Opportunities
  7. Global Reproductive Genetics Market Trends & Developments
  8. Global Reproductive Genetics Research and Development Activities
  9. Global Reproductive Genetics Market Regulations, By Region
    1. The US
    2. EU
    3. Germany
    4. France
    5. The UK
    6. China
    7. Japan
    8. South Korea
    9. Others
  10. Global Reproductive Genetics Market Intellectual Property Rights Analysis
    1. Patents Filed YoY
  11. Global Reproductive Genetics Market Outlook, 2018-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Procedure Type
        1. Carrier Screening
        2. Pre-Natal Screening
        3. Pre-Implantation Genetic Testing
        4. Infertility Genetic Testing
      2. By Product Type
        1. Kits
        2. Laboratory Developed Tests
        3. Reagents & Consumables
      3. By Technology
        1. Next Generation Sequencing
        2. Polymerase Chain Reaction
        3. In-Situ Hybridization
        4. Microarray
      4. By Application
        1. Aneuploidy
        2. Structural Chromosomal Abnormality
        3. Single Gene Disorder
        4. Others 
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia Pacific
      6. By Company
  12. North America Reproductive Genetics Market Outlook, 2018-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Procedure Type
      2. By Technology
      3. By Country
        1. The US Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
        2. Canada Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
        3. Mexico Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
  13. South America Reproductive Genetics Market Outlook, 2018-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Procedure Type
      2. By Technology
      3. By Country
        1. Brazil Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
  14. Europe Reproductive Genetics Market Outlook, 2018-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Procedure Type
      2. By Technology
      3. By Country
        1. Germany Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
        2. France Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
        3. The UK Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
        4. Spain Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
        5. Italy Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
  15. Middle East & Africa Reproductive Genetics Market Outlook, 2018-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Procedure Type
      2. By Technology
  16. Asia Pacific Reproductive Genetics Market Outlook, 2018-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Procedure Type
      2. By Technology
      3. By Country
        1. China Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
        2. Japan Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
        3. India Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
        4. South Korea Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
        5. Australia Reproductive Genetics Market Outlook, 2018-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By Procedure Type
  17. Company Profiles
    1. ThermoFisher Scientific
    2. Eurofins Scientific SE
    3. Natera Inc.
    4. BGI Genomics
    5. Illumina, Inc.
    6. Agilent Technologies, Inc.
    7. CENTOGENE AG
    8. Fulgent Genetics, Inc.
    9. F. Hoffmann-La Roche Ltd  
    10. Invitae Corporation
    11. Laboratory Corporation of America Holdings
    12. PerkinElmer, Inc.
    13. Myriad Genetics, Inc.
    14. OPKO Health, Inc.
    15. Quest Diagnostics
    16. QIAGEN NV
  18. Disclaimer
Reproductive Genetics Market Segmentation